The NBA’s Houston Rockets Implement Glenco Medical’s COVID-19 Testing Protocols to Commence Training for 2020-2021 NBA Season - Seite 2

The Standard for Safe Sport is a trademarked protocol developed originally by Glenco Medical, in which QuestCap owns a 30% equity interest, and is headed by renowned MLB physician, Dr. Glenn Copeland.

“We are very excited to be able to partner with the Houston Rockets and help them restore the spirit of competition and conditioning responsibly,” commented Doug Sommerville, QuestCap CEO. “We know the importance of safety in the professional sports realm and are proud to help empower a culture for both winning and safety with Glenco Medical’s protocols and QuestCap’s high-quality antibody and antigen testing solutions. We look forward to extending this to other teams that require our complete COVID-19 safety protocols.”

About Houston Rockets

The Houston Rockets are an American professional basketball team based in Houston. The Rockets compete in the National Basketball Association (NBA) as a member team of the league's Western Conference Southwest Division. The team plays its home games at the Toyota Center, located in Downtown Houston. Throughout its history, Houston has won two NBA championships and four Western Conference titles. It was established in 1967 as the San Diego Rockets, an expansion team originally based in San Diego. In 1971, the Rockets relocated to Houston.

About QuestCap Inc.
QuestCap Inc. (NEO:QSC; OTC:COPRF; FRA:34C1)  seeks out disruptive technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate remarkable risk-adjusted returns for investors. Specifically, QuestCap offers investors a diversified investment in the COVID-19 medical space across three areas; prevention, detection, and treatment.

QuestCap has a team of renowned global medical and business advisors that have developed a proprietary business strategy to capitalize on high-margin opportunities in the COVID-19 space. This panel includes prominent immunologist Dr. Lawrence Steinman and Dr. Glenn Copeland, who has 45 years of experience in orthopaedic treatment, foot and ankle care, and sports medicine.

QuestCap’s primary focus is the sale of COVID-19 IgG/IgM antibody tests authorized by FDA under an EUA for use by authorized laboratories. This is achieved largely through two acquisitions: 100% of Collection Sites, LLC and 28% of Colombian Sanaty IPS. Collection Sites is setting up a series of COVID-19 testing sites across the United States with appointments and payments will be handled through the online portal  www.testbeforeyougo.com. Sanaty is setting up a series of full-service medical clinics offering a complete COVID-19 testing solution.